Publications en collaboration avec des chercheurs de United States Food and Drug Administration (21)

2020

  1. An atlas of O-linked glycosylation on peptide hormones reveals diverse biological roles

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Report of a TREAT-NMD/World duchenne organisation meeting on dystrophin quantification methodology

    Journal of Neuromuscular Diseases

2016

  1. CD300c is uniquely expressed on CD56bright Natural Killer Cells and differs from CD300a upon ligand recognition

    Scientific Reports, Vol. 6

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Fc receptor-like 5 expression distinguishes two distinct subsets of human circulating tissue-like memory b cells

    Journal of Immunology, Vol. 196, Núm. 10, pp. 4064-4074

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  5. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults

    Scientific Reports, Vol. 6

2015

  1. A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells

    PLoS ONE, Vol. 10, Núm. 4

2013

  1. CD300c is an activating receptor expressed on human monocytes

    Journal of Innate Immunity, Vol. 5, Núm. 4, pp. 389-400

  2. Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy

    Clinical and Experimental Immunology, Vol. 173, Núm. 1, pp. 131-139

  3. The CD300 molecules: An emerging family of regulators of the immune system

    Blood, Vol. 121, Núm. 11, pp. 1951-1960

2012

  1. Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a

    BMC Immunology, Vol. 13

  2. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells

    Blood, Vol. 119, Núm. 12, pp. 2799-2809

  3. Leukocyte-associated Ig-like receptor-1 - Deficient mice have an altered immune cell phenotype

    Journal of Immunology, Vol. 188, Núm. 2, pp. 548-558

  4. Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells

    Journal of Immunology, Vol. 189, Núm. 2, pp. 587-597

  5. U.S. Food and Drug Administration approval summary: Brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma

    Clinical Cancer Research, Vol. 18, Núm. 21, pp. 5845-5849

2011

  1. Complex regulation of human NKG2D-DAP10 cell surface expression: Opposing roles of the γc cytokines and TGF-β1

    Blood, Vol. 118, Núm. 11, pp. 3019-3027

  2. Differential expression of CD300a/c on human TH1 and TH17 cells

    BMC Immunology, Vol. 12

2010

  1. Human Th1 Cells That Express CD300a Are Polyfunctional and After Stimulation Up-Regulate the T-Box Transcription Factor Eomesodermin

    PLoS ONE, Vol. 5, Núm. 5

2009

  1. Endocytosis and intracellular trafficking of human natural killer cell receptors

    Traffic, Vol. 10, Núm. 12, pp. 1735-1744